DSGN vs ZION · $214.0M cap vs P/E 11, rev $354.0M
Design Therapeutics Inc (DSGN) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported DSGN revenue for 2025-12-31 was $0. Net income was -$69.8M. DSGN currently screens at market cap $214.0M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
DSGN currently screens at market cap $214.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the DSGN and ZION stock pages for the full models.
Not investment advice.